Skip to main content

FUNCION DUAL DEL TRANSPORTADOR ABCG2 EN LA EXCRECION DE NUEVAS MOLECULAS DE SABOR Y CONTAMINANTES ALIMENTARIOS INCLUYENDO MICOTOXINAS EN LECHE DE RUMIANTES Y EXOSOMAS

PID2021-125660OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2021
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE LEÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Tesis doctoral (DoctoralThesis)

Papel dual del transportador ABCG2 en la secreción a leche de compuestos endógenos y fármacos con actividad antiparasitaria, Dual role of the ABCG2 transporter in the secretion into milk of endogenous compounds and drugs with antiparasitic activity

  • Álvarez Fernández, Laura
197 p., [ES] El transportador ATP-Binding Cassette G2 (ABCG2) es una proteína integral de membrana perteneciente a la subfamilia G de los transportadores ATP-Binding Cassette (ABC) que funciona como una bomba de eflujo poliespecífica capaz de exportar un amplio espectro de sustancias de diversa naturaleza molecular (compuestos endógenos, naturales, fármacos y otros xenobióticos) hacia el exterior de las células (Eckenstaler y Benndorf, 2020). Esta proteína se expresa en la membrana apical de las células de numerosos tejidos y órganos de interés farmacológico y toxicológico implicados en la biodisponibilidad de sus sustratos tales como el intestino, el hígado o el riñón, así como en las principales barreras fisiológicas (hematoencefálica, hematotesticular y fetoplacentaria) (Vlaming et al., 2009; Stacy et al., 2013), regulando la entrada de sustancias no deseadas, como ciertas toxinas, al interior del organismo. Además, es uno de los principales responsables de la ampliamente conocida resistencia frente a múltiples fármacos (Duvivier et al., 2024). En contraposición al papel protector previamente descrito, ABCG2 también participa en el paso a leche de numerosas moléculas incluyendo algunos fármacos de uso veterinario, como los antiparasitarios, los cuales representan el sector más importante de la industria farmacéutica animal (Blanco-Paniagua et al., 2022a). Asimismo, participa en la secreción de algunas vitaminas, como la riboflavina y el ácido fólico, y de compuestos estrogénicos, como los fitoestrógenos, a la leche (van Herwaarden et al., 2007; García Mateos et al., 2017)., [EN] Considering that milk is a crucial food source for the optimal growth and development of mammals, as well as a vital component of human diet worldwide, understanding any factor that could affect the transport of xenobiotics (such as drugs) or natural substances (such as vitamins and hormones) to milk is a priority. This knowledge is essential to predict and mitigate potential unexpected contamination of dairy products and to produce safe, high-quality milk with improved nutritional value. In dairy animals, the use of antiparasitic agents is a widespread practice for treatment and prevention of parasitic diseases (Lanusse et al., 2018). However, despite its undoubted benefits, the potential risk of unwanted elimination of pharmacological residues in food products intended for human consumption, such as milk, is a major concern for food safety and public health (Virkel et al., 2018). Conversely, milk transfer of beneficial endogenous compounds naturally synthesized by the animal, such as vitamins, could improve the nutritional quality of dairy products for consumers (García-Lino et al., 2019). In this context, and due to its relevant role in the secretion of its substrates into milk, as well as its influence on their plasma and tissue profile, the study of the interaction of the ABCG2 transporter with compounds present in milk both naturally and after exogenous administration is of particular relevance. Interestingly, the physiological role of this protein in the mammary gland remains slightly paradoxical. ABCG2 is known to facilitate the transfer of essential nutrients and vitamins, such as folic acid and riboflavin, to newborn. However, it is also responsible for the secretion of toxic substances, including certain drugs, into milk, which could pose risks to both breast-fed infants and consumers of dairy products (Imperiale & Lanusse, 2021). Given this dual role, the primary goal of our research group is to understand why a protein that apparently protects the body from xenobiotic exposure can also facilitate the accumulation of toxic substrates in milk, a function that seems difficult to reconcile with the need to protect the offspring. Considering the aforementioned, this PhD Thesis aimed to explore the involvement of ABCG2 in the in vitro transport, plasma and tissue bioavailability, and milk secretion of the endogenous compound melatonin, and the antiparasitic drugs thiabendazole and nitroxynil. To achieve this goal, a common methodology was employed. First, in vitro transepithelial transport assays were conducted using Madin-Darby Canine Kidney II (MDCK-II) cells and its subclones transduced with the murine, ovine, bovine, and human isoforms of the ABCG2 transporter to evaluate its role in the active transport of these molecules. Second, in vivo studies were performed using male wild-type and Abcg2(–/–) mice to assess the effect of this transporter on plasma bioavailability and tissue distribution of these compounds. Third, lactating mice were used to examine whether the Abcg2 transporter influences their milk secretion. Finally, metabolomic analyses were carried out to determine the impact of ABCG2 on milk metabolome.